J&J Reshapes Its Future: Strategic Spin-Off of Orthopedics Arm Signals New Era of Growth
Johnson & Johnson’s decision to spin off its orthopedics division marks a defining strategic shift for one of the world’s most enduring healthcare conglomerates. The move underscores a fundamental realignment of priorities — from slow-growth legacy operations to a focused push on higher-margin, innovation-driven sectors such as oncology, immunology, and cardiovascular care. Under the plan,…









